1. Home /
  2. Drug Approvals

Drug Approvals

Biotech and Broadway Come Together to Fight Cancer

Biotech and Broadway Come Together to Fight Cancer

Cancer affects all of us. But the Damon Runyon Cancer Research Foundation has invested $355 million (and counting) in research to fight it. We spent time with its CEO to hear about her journey and how immunotherapies are taking the lead.

CBD Doesn't Get You High, But Could Someday Eclipse the Entire Pot Industry

CBD Doesn't Get You High, But Could Someday Eclipse the Entire Pot Industry

Cannabidiol, or CBD, is a cannabis extract that's used to treat everything from pain to opiate addiction to PTSD. It doesn't get you high -- but advocates say that's the reason that CBD could soon eclipse the multibillion-dollar pot industry.

Names to Watch Amid Biotech's Nascent Rally

Names to Watch Amid Biotech's Nascent Rally

Progenics and Tesaro are among sagging small-cap biotech stocks that could rebound in coming months.

Can Legal Cannabis Help Slow the Opioid Drug Epidemic in the U.S.?

Can Legal Cannabis Help Slow the Opioid Drug Epidemic in the U.S.?

More research is needed, but medical experts agree that cannabis plants have immense potential to slow opioid drug overdoses, which claim 115 lives every day in the U.S.

How the Netflix Model Is Making Its Way to the Health Care Space

How the Netflix Model Is Making Its Way to the Health Care Space

The Netflix direct to consumer model is making its way to the health care space.

If We Got Boehner, We Can Get Anyone: Washington's Growing Role in Cannabis

If We Got Boehner, We Can Get Anyone: Washington's Growing Role in Cannabis

Cannabis isn't a red and blue issue in Washington. Here's how the political landscape is changing as marijuana prohibition becomes 'politically untenable.'

3 Small Biotechs Turn on the Revenue Jets

3 Small Biotechs Turn on the Revenue Jets

BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.

This Company Is at the Center of Insider Trading Charges Against Rep. Collins

This Company Is at the Center of Insider Trading Charges Against Rep. Collins

Innate Immunotherapeutics of Australia is the biopharmaceutical company at the center of the insider trading charges leveled against New York Rep. Chris Collins.

How to Play Biotech 'Sell the News' Pattern

How to Play Biotech 'Sell the News' Pattern

Patient investors can profit from small-cap biotech stocks that often slide once positive news comes out.

Jim Cramer on Johnson & Johnson's Pharmaceuticals Sales Growth

Jim Cramer on Johnson & Johnson's Pharmaceuticals Sales Growth

When investors review a drug company, pay close attention to its pharma performance, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.